These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27301780)

  • 1. Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
    Prasad B; Gaedigk A; Vrana M; Gaedigk R; Leeder JS; Salphati L; Chu X; Xiao G; Hop C; Evers R; Gan L; Unadkat JD
    Clin Pharmacol Ther; 2016 Oct; 100(4):362-70. PubMed ID: 27301780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex.
    Prasad B; Evers R; Gupta A; Hop CE; Salphati L; Shukla S; Ambudkar SV; Unadkat JD
    Drug Metab Dispos; 2014 Jan; 42(1):78-88. PubMed ID: 24122874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.
    Mooij MG; Schwarz UI; de Koning BA; Leeder JS; Gaedigk R; Samsom JN; Spaans E; van Goudoever JB; Tibboel D; Kim RB; de Wildt SN
    Drug Metab Dispos; 2014 Aug; 42(8):1268-74. PubMed ID: 24829289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
    Rizk ML; Houle R; Chan GH; Hafey M; Rhee EG; Chu X
    Antimicrob Agents Chemother; 2014; 58(3):1294-301. PubMed ID: 24295974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.
    Tsakalozou E; Adane ED; Kuo KL; Daily A; Moscow JA; Leggas M
    Drug Metab Dispos; 2013 Jul; 41(7):1404-13. PubMed ID: 23620484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
    Zhang Y; Ruggiero M; Hagenbuch B
    Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.
    Ieiri I; Higuchi S; Sugiyama Y
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
    Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
    PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies.
    Shimizu R; Matsuzaki T; Oka R; Sonoyama T; Fukuhara T; Kuwata A; Matsuo Y; Kubota R
    J Clin Pharmacol; 2023 Aug; 63(8):918-927. PubMed ID: 37043676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Abundance of Drug Transporters in Human Hepatitis C Livers.
    Droździk M; Lapczuk-Romanska J; Wenzel C; Skalski Ł; Szeląg-Pieniek S; Post M; Syczewska M; Kurzawski M; Oswald S
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
    Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
    PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients.
    Hahn D; Fukuda T; Euteneuer JC; Mizuno T; Vinks AA; Sadhasivam S; Emoto C
    J Clin Pharmacol; 2020 Aug; 60(8):992-998. PubMed ID: 32090339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.
    Jiang R; Dong J; Li X; Du F; Jia W; Xu F; Wang F; Yang J; Niu W; Li C
    Br J Pharmacol; 2015 Feb; 172(4):1059-73. PubMed ID: 25297453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
    Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
    Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens.
    Li CY; Gupta A; Gáborik Z; Kis E; Prasad B
    Mol Pharmacol; 2020 Sep; 98(3):234-242. PubMed ID: 32587096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.
    Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP
    Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.
    Cherrington NJ; Slitt AL; Li N; Klaassen CD
    Drug Metab Dispos; 2004 Jul; 32(7):734-41. PubMed ID: 15205389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of expression of hepatic organic anion-transporting polypeptide (OATP) transporters in cellular systems relative to human liver tissue.
    Badée J; Achour B; Rostami-Hodjegan A; Galetin A
    Drug Metab Dispos; 2015 Apr; 43(4):424-32. PubMed ID: 25564656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.